These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3042215)

  • 1. Metabolic effects of continuous subcutaneous insulin infusion: evidence that a rise and fall of portal vein insulin concentration with each major meal facilitates post-absorptive glycemic control.
    Rodger NW; Behme MT; Dupre J; Chamberlain MJ
    Clin Invest Med; 1988 Jun; 11(3):167-86. PubMed ID: 3042215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas.
    Jennings AM; Lewis KS; Murdoch S; Talbot JF; Bradley C; Ward JD
    Diabetes Care; 1991 Aug; 14(8):738-44. PubMed ID: 1954811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion in adults: glycemic advantage is predicted by venous plasma C-peptide concentrations.
    Rodger NW; Dupre J; Canny CL; Brown WF
    Diabetes Care; 1985; 8(5):447-55. PubMed ID: 3902423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion treatment in insulin-dependent diabetic patients: a comparison with conventional optimized treatment in a long-term study.
    Calabrese G; Bueti A; Santeusanio F; Giombolini A; Zega G; Angeletti G; Cartechini MG; Brunetti P
    Diabetes Care; 1982; 5(5):457-65. PubMed ID: 7188333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A crossover comparison of continuous insulin infusion and conventional injection treatment of type I diabetes.
    Helve E; Koivisto VA; Lehtonen A; Pelkonen R; Huttunen JK; Nikkilä EA
    Acta Med Scand; 1987; 221(4):385-93. PubMed ID: 3300175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma immunoreactive somatostatin response to arginine after glycemic control with continuous subcutaneous insulin infusion in type I diabetics.
    Kobayashi T; Sawano S; Itoh T; Kosaka K
    Diabetes Care; 1987; 10(3):286-92. PubMed ID: 2885161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic control in newly kidney transplanted insulin-dependent diabetics: improvement by insulin pump treatment (CSII).
    Schmitz O; Sorensen SS; Alberti KG; Orskov H; Hansen HE
    J Diabet Complications; 1987; 1(3):81-6. PubMed ID: 2969910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on C-peptide and free insulin in the blood during continuous subcutaneous insulin infusion and conventional insulin therapy.
    Bergenstal RM; Dupre J; Lawson PM; Rizza RA; Rubenstein AH
    Diabetes; 1985 Aug; 34 Suppl 3():31-6. PubMed ID: 3926568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission from insulin dependence induced by continuous subcutaneous insulin infusion (CSII) in type I, newly diagnosed diabetics: role of some hormonal and immunologic factors.
    Nardelli GM; Guastamacchia E; Di Paolo S; Lattanzi V; Ciampolillo A; Montedoro P; Giorgino R
    Acta Diabetol Lat; 1988; 25(4):343-50. PubMed ID: 3266701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous insulin infusion versus injection therapy: a randomized cross-over trial under usual diabetic clinic conditions.
    Marshall SM; Home PD; Taylor R; Alberti KG
    Diabet Med; 1987; 4(6):521-5. PubMed ID: 2962807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
    Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
    Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counterregulatory hormone responses after long-term continuous subcutaneous insulin infusion with lispro insulin.
    Tsui EY; Chiasson JL; Tildesley H; Barnie A; Simkins S; Strack T; Zinman B
    Diabetes Care; 1998 Jan; 21(1):93-6. PubMed ID: 9538976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial.
    de Beaufort CE; Houtzagers CM; Bruining GJ; Aarsen RS; den Boer NC; Grose WF; van Strik R; de Visser JJ
    Diabet Med; 1989 Dec; 6(9):766-71. PubMed ID: 2533034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study.
    Lepore G; Dodesini AR; Nosari I; Trevisan R
    Diabetes Nutr Metab; 2004 Apr; 17(2):84-9. PubMed ID: 15244099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.
    Hirsch IB; Bode BW; Garg S; Lane WS; Sussman A; Hu P; Santiago OM; Kolaczynski JW;
    Diabetes Care; 2005 Mar; 28(3):533-8. PubMed ID: 15735183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High density lipoprotein subfractions during continuous insulin infusion therapy.
    Helve E
    Atherosclerosis; 1987 Apr; 64(2-3):173-80. PubMed ID: 3300667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overnight metabolic control with bedtime injection of intermediate-acting insulin or continuous subcutaneous insulin infusion.
    Olsson PO; Arnqvist H; Von Schenck H; Ottosson AM
    Diabetes Care; 1987; 10(6):702-6. PubMed ID: 3322726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus.
    Bagdade JD; Helve E; Taskinen MR
    Metabolism; 1991 May; 40(5):445-9. PubMed ID: 2023530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein changes during continuous subcutaneous insulin infusion in insulin-dependent diabetic patients.
    Møller A; Rasmussen L; Ledet T; Christiansen JS; Christensen CK; Mogensen CE; Hermansen K
    Scand J Clin Lab Invest; 1986 Sep; 46(5):471-5. PubMed ID: 3529352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.